REGN

Regeneron Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.29 0.05% 640.63 629.00 655.9255 648.00 640.34 17:06:36
more quote information »

Recent News

Date Time Source Heading
7/08/202016:30PRNUSRegeneron to Report Second Quarter 2020 Financial and..
7/08/202016:23EDGARStatement of Changes in Beneficial Ownership (4)
7/08/202016:20EDGARStatement of Changes in Beneficial Ownership (4)
7/07/202012:30DJNU.S. Commits $2 Billion for Covid-19 Vaccine, Drug Supplies..
7/07/202010:59DJNU.S. Commits $2 Billion for Covid-19 Vaccine, Drug Supplies
7/07/202007:44DJNRegeneron Gets Federal Manufacturing Contract for Covid-19..
7/07/202007:29EDGARCurrent Report Filing (8-k)
7/07/202007:00PRNUSRegeneron Announces Manufacturing and Supply Agreement for..
7/06/202012:40DJNRegeneron Advances Covid-19 Drug Into Later-Stage Testing
7/06/202007:48DJNRegeneron Embarks on Phase 3 Covid-19 Prevention Trial
7/06/202007:00PRNUSRegeneron Announces Start of REGN-COV2 Phase 3 COVID-19..
7/02/202018:17DJNArthritis Drug Fails in Study of Covid-19 Patients
7/02/202017:22DJNRegeneron, Sanofi Say Kevzara Phase 3 U.S. Trial in Covid-19..
7/02/202016:31EDGARStatement of Changes in Beneficial Ownership (4)
7/02/202016:29EDGARStatement of Changes in Beneficial Ownership (4)
6/30/202016:03EDGARStatement of Changes in Beneficial Ownership (4)
6/29/202016:09EDGARStatement of Changes in Beneficial Ownership (4)
6/29/202008:15DJNKiniksa: Phase 3 Rilonacept Study Meets Key Endpoints in..
6/26/202014:43DJNCorrection to Coronavirus Treatment Article
6/26/202009:32DJNThe Butcher's Son Seeking a Drug That Can Cut Down..
6/24/202016:04EDGARStatement of Changes in Beneficial Ownership (4)
6/24/202015:22PRNUSRegeneron to Vigorously Defend Allegations Related to..
6/24/202014:00PRNUSNew Publication Highlights Preclinical Research Showing..
6/22/202016:19EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202007:00PRNUSRegeneron Announces the 2020 Winners of the Regeneron Prize..
6/19/202013:51PRNUSFDA approves new Dupixent® (dupilumab) pre-filled pen..
6/19/202013:44PRNUSFDA Approves New Dupixent® (dupilumab) Pre-filled Pen..
6/19/202007:30PRNUSDupixent® (dupilumab) Approved in China for Adults with..
6/17/202017:11EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
6/17/202016:03EDGARStatement of Changes in Beneficial Ownership (4)
6/16/202016:34EDGARCurrent Report Filing (8-k)
6/16/202016:03EDGARSecurities Registration: Employee Benefit Plan (s-8)
6/12/202016:03EDGARStatement of Changes in Beneficial Ownership (4)
6/12/202016:02EDGARStatement of Changes in Beneficial Ownership (4)
6/11/202018:46EDGARStatement of Changes in Beneficial Ownership (4)
6/11/202007:17PRNUSTwo Science Publications Highlight Potential of REGN-COV2..
6/11/202007:00PRNUSRegeneron Begins First Clinical Trials of Anti-Viral..
6/11/202000:59PRNUSRegeneron Collaborations on Dupixent® (dupilumab)..
6/10/202016:05EDGARStatement of Changes in Beneficial Ownership (4)
6/10/202010:14EDGARStatement of Ownership (sc 13g)
6/10/202009:00PRNUSRegeneron Recognized as Healthcare Sector Leader on "The..
6/09/202016:06EDGARStatement of Changes in Beneficial Ownership (4)
6/08/202009:00PRNUSRegeneron Announces Virtual-Only Format for 2020 Annual..
6/08/202008:48EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
6/05/202016:16EDGARStatement of Changes in Beneficial Ownership (4)
6/05/202007:00PRNUSRegeneron Announces Upcoming Investor Conference..
6/02/202016:04EDGARStatement of Changes in Beneficial Ownership (4)
6/01/202016:09EDGARStatement of Changes in Beneficial Ownership (4)
6/01/202016:03EDGARStatement of Changes in Beneficial Ownership (4)
6/01/202007:00PRNUSRegeneron and Intellia Therapeutics Expand Collaboration to..
See more news about this stock »
Your Recent History
NASDAQ
REGN
Regeneron ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200709 21:54:24